FORM SC 13G

Company

NRX Pharmaceuticals, Inc.

Filed

February 1, 2018

Accession Number

0001062993-18-000392

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →